Better Coronavirus Stock: Inovio Pharmaceuticals vs. Vir Biotechnology
Better Coronavirus Stock: Inovio Pharmaceuticals vs. Vir Biotechnology 1COVID-19, the disease caused by the novel coronavirus, has been officially labeled a pandemic by the World Health Organization (WHO). In the U.S., there are now more than 1,200 confirmed cases and at least 29 deaths. Globally, over 100 countries have reported cases of COVID-19, and nearly 5,000 people have died from it. The stock market has …
News story posted on 2020-03-15T17:30:00.0000000Z